LOS ANGELES, Sept. 1 /PRNewswire/ -- Prominent buildings around Los Angeles are turning blue tonight in support of Blue September. The iconic Capital Records Building and Paramount Studio's Melrose Gate and Water Tower and the historic Ramada West Hollywood will all be bathed in blue light, gifting motorists and spectators with a unique once-off view of the familiar Los Angeles skyline.
Blue September is a prostate cancer awareness and fundraising campaign seeking to highlight in blue the lack of representation given to this insidious disease, which claims as many lives every year as breast cancer but with nowhere near the same public attention.
"Capitol Records hopes that by turning the Tower blue it will capture the public's attention on the great work that 'Blue September' is doing to raise awareness for early detection of prostate cancer. It's our small part in making a big difference," said Jim Kuha, Senior Director of EMI Music North America.
It is hoped this very public show of support for Blue September will leave a lasting impression on the people of and visitors to Los Angeles, encouraging them to face up to prostate cancer.
The Los Angeles buildings embracing the Get Blue message includes:
* Capitol Records building
* Paramount Studios Melrose Gate and Water Tower
* The Ramada West Hollywood
* The Roosevelt Hotel
The lighting of the Capital Records building is made possible by V Wine Cellar and Villagio Spa and Inn, Napa Valley.
Blue is for boys - so it's time to get BLUE California and face up to prostate cancer!
More than 27,000 American men are expected to die from prostate cancer this year, with over 2 million Americans living with the disease.
Blue September is the campaign created to get men to face up to prostate cancer.
Ultimately, the goal is to change changing attitudes and behaviors towards prostate cancer whilst raising funds for The Prostate Cancer Research Institute.
The Prostate Cancer Research Institute was founded in 1996, with the objective of educating patients and their families about prostate cancer. This includes new advances in diagnosis, staging, treatments and available resources. The PCRI operate under the philosophy that patient who understands his disease and treatment is empowered to communicate more effectively with his physicians and obtain a better outcome.
For more information and contact:
Craig Thornton on +1 415 377 8410 or
email@example.com or go to www.blueseptember.org
SOURCE Prostate Cancer Reseearch Institute